Back to today’s briefing

Story perspectives

29-Year-Old Man Shows Remarkable Recovery from Lymphoma

10/23/2025

38 4

Summary

Story summary

On March 11, 2025, biopsy confirmed diffuse large B cell lymphoma (DLBCL), nongerminal center B cell type, in a 29-year-old male.
The patient began Pola-R-CHP chemotherapy and showed significant improvements in symptoms and blood parameters after two cycles.
A CT scan showed a 50% reduction in splenic nodules and lymph nodes under 10 mm.
The patient is high-risk with an age-adjusted International Prognostic Index score of 3 and continues follow-up.

1 of 1

Story summary

On March 11, 2025, biopsy confirmed diffuse large B cell lymphoma (DLBCL), nongerminal center B cell type, in a 29-year-old male.
The patient began Pola-R-CHP chemotherapy and showed significant improvements in symptoms and blood parameters after two cycles.
A CT scan showed a 50% reduction in splenic nodules and lymph nodes under 10 mm.
The patient is high-risk with an age-adjusted International Prognostic Index score of 3 and continues follow-up.